Medical Developments International Ltd (MVP):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Medical Developments International Ltd (MVP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12346
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Medical Developments International Ltd (MDI) is a healthcare company that develops, manufactures and markets pain relief and respiratory medicine. The company provides products such as penthrox, asthma and COPD, medical devices and veterinary products. It offers asthma and COPD products which include autoclavable space chamber breath alert peak flow meter, compact space chamber, disposable face mask, MDI silicone face mask and others. MDI offers medical devices which include CPR face shield key ring, CPR mask, CPR resuscitation pocket mask, finger pulse oximeter and hudson mask with reservoir bag. The company operates manufacturing facilities located in Victoria. It also operates in Canada and the UK. MDI is headquartered in Scoresby, Victoria, Australia.

Medical Developments International Ltd (MVP) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Medical Developments International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Medical Developments International Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Medical Developments International Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Medical Developments International Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Medical Developments International Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Medical Developments International Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Medical Developments International Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
JSC Lancet Enters into Licensing Agreement with Medical Developments International for Penthrox 11
Purdue Pharma Enters Into Licensing Agreement With Medical Developments 12
Medical Developments to Enter into Licensing Agreement for Penthrox in Canada 13
Mundipharma Enters into Licensing Agreement with Medical Developments for Penthrox 14
Galen Enters Into Licensing Agreement With Medical Developments International For Penthrox 15
Medical Developments International Plans to Enter into Licensing Agreement for Penthrox 16
Equity Offering 17
Medical Developments Raises USD12.6 Million in Private Placement of Shares 17
Medical Developments to Raise Funds through Share Purchase Plan 18
Medical Developments International Ltd – Key Competitors 19
Medical Developments International Ltd – Key Employees 20
Medical Developments International Ltd – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Financial Announcements 22
May 14, 2018: Medical Developments International:Trading Update 22
Feb 20, 2017: Medical Developments Reports Revenue Of AUD8m In H1 Fiscal 2017 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Medical Developments International Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Medical Developments International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Medical Developments International Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Medical Developments International Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Medical Developments International Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Medical Developments International Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Medical Developments International Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
JSC Lancet Enters into Licensing Agreement with Medical Developments International for Penthrox 11
Purdue Pharma Enters Into Licensing Agreement With Medical Developments 12
Medical Developments to Enter into Licensing Agreement for Penthrox in Canada 13
Mundipharma Enters into Licensing Agreement with Medical Developments for Penthrox 14
Galen Enters Into Licensing Agreement With Medical Developments International For Penthrox 15
Medical Developments International Plans to Enter into Licensing Agreement for Penthrox 16
Medical Developments Raises USD12.6 Million in Private Placement of Shares 17
Medical Developments to Raise Funds through Share Purchase Plan 18
Medical Developments International Ltd, Key Competitors 19
Medical Developments International Ltd, Key Employees 20

List of Figures
Medical Developments International Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Medical Developments International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Medical Developments International Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Medical Developments International Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Medical Developments International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Medical Developments International Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Medical Developments International Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Medical Developments International Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Medical Developments International Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Medical Developments International Ltd (MVP):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BrainLAB AG:医療機器:M&Aディール及び事業提携情報
    Summary BrainLAB AG (Brainlab) is a medical technology company that develops, manufactures and markets medical technology facilitated by software that helps optimize treatment outcomes. The company provides technological solutions in radiosurgery and numerous surgical fields such as neurosurgery, or …
  • Medigard Ltd (MGZ)-医療機器分野:企業M&A・提携分析
    Summary Medigard Ltd (Medigard), formerly Medisafe Instruments Pty Ltd is a medical device company that designs and develops retractable safety medical devices. The company offers products such as auto-retractable syringe, manual retractable syringe, blood collection device, intravenous valve and fl …
  • Itausa – Investimentos Itau SA (ITSA4):企業の財務・戦略的SWOT分析
    Itausa - Investimentos Itau SA (ITSA4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Navamedic ASA (NAVA):企業の財務・戦略的SWOT分析
    Navamedic ASA (NAVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • VPK Packaging Group NV:企業の戦略・SWOT・財務情報
    VPK Packaging Group NV - Strategy, SWOT and Corporate Finance Report Summary VPK Packaging Group NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Toei Animation Co., Ltd. (4816):企業の財務・戦略的SWOT分析
    Toei Animation Co., Ltd. (4816) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • TransMontaigne Product Services LLC:企業の戦略的SWOT分析
    TransMontaigne Product Services LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Airbus SAS:戦略・SWOT・企業財務分析
    Airbus SAS - Strategy, SWOT and Corporate Finance Report Summary Airbus SAS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Takara Bio Inc (4974):製薬・医療:M&Aディール及び事業提携情報
    Summary Takara Bio Inc (Takara), a subsidiary of Takara Holdings Inc, is a biotechnology company that develops, manufactures and distributes biotechnology research reagents and equipments for life sciences research. The company sells gene amplification system and offers scientific instruments. It of …
  • Zoo Digital Group plc (ZOO):企業の財務・戦略的SWOT分析
    Summary Zoo Digital Group Plc (ZOO) is a technology company that offers localization and media production services. The company offers services such as subtitling, captioning, dubbing and digital distribution. Its activities include providing a range of services to allow television and movie content …
  • Radboud University Medical Centre:製薬・医療:M&Aディール及び事業提携情報
    Summary Radboud University Medical Centre (Radboud UMC), a subsidiary of Radboud University, is a university medical center that offers patient care, education, research, and scientific training services. The centre’s patient care services include basic care, tertiary care, top referral care, and tr …
  • Fraport Slovenija, d.o.o.:企業の戦略・SWOT・財務情報
    Fraport Slovenija, d.o.o. - Strategy, SWOT and Corporate Finance Report Summary Fraport Slovenija, d.o.o. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Dexia Group:企業のM&A・事業提携・投資動向
    Dexia Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dexia Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Spineology Inc:医療機器:M&Aディール及び事業提携情報
    Summary Spineology Inc (Spineology) is a medical device company that develops and designs spinal implants. The company offers products such as pedicular fixation system, interbody fusion system, deployable grafting system, amniotic fixation system, allografts, retractor system, liquid tissue matrix, …
  • Assembly Biosciences Inc (ASMB):企業の財務・戦略的SWOT分析
    Summary Assembly Biosciences Inc (Assembly), formerly Ventrus Biosciences Inc is a biotechnology company that develops, discovers, and commercializes small molecule therapies. The company develops therapies for the treatment of infectious diseases such as microbiotic therapies for Clostridium diffic …
  • Hetero Drugs Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Hetero Drugs Ltd (Hetero) is a manufacturer of active pharmaceutical ingredients, intermediate chemicals and finished dosages. The company specializes in process chemistry, API manufacturing, formulation development, manufacturing and commercialization of bio-generics, and also offers custom …
  • Bio-Rad Laboratories Inc (BIO):企業の財務・戦略的SWOT分析
    Bio-Rad Laboratories Inc (BIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Sappi Limited:企業の戦略・SWOT・財務分析
    Sappi Limited - Strategy, SWOT and Corporate Finance Report Summary Sappi Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Heineken NV:企業のM&A・事業提携・投資動向
    Heineken NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Heineken NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Air Berlin PLC & Co. Luftverkehrs KG:戦略・SWOT・企業財務分析
    Air Berlin PLC & Co. Luftverkehrs KG - Strategy, SWOT and Corporate Finance Report Summary Air Berlin PLC & Co. Luftverkehrs KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆